Knop Laboratorios
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment. (NCT04239469) | Knop Laboratorios | 2020-01-15 |
Track Knop Laboratorios automatically
Every clearance here is in the API, with alerts when new ones post.